Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Personalized Medicine Approach for Beta-thalassemia Transfusion Dependent Patients: Testing SIROLIMUS in a First Pilot Clinical Trial

NCT03877809 is registered in ClinicalTrials.gov with Rare Partners srl Impresa Sociale as lead sponsor.

NCT NCT03877809
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03877809 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Personalized Medicine Approach for Beta-thalassemia Transfusion Dependent Patients: Testing SIROLIMUS in a First Pilot Clinical Trial
Lead sponsor
Rare Partners srl Impresa Sociale
Phase
Phase 2
Overall status
Completed
Start date
June 27, 2019
Completion date
April 30, 2022
Enrollment
26 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

beta-thalassemia